Cargando…
Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure
BACKGROUND AND AIMS: Nonbiological artificial liver (NBAL) is frequently used as a first-line treatment for hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF). This study aimed to compare the therapeutic efficacy and cost-effectiveness ratio (CER) of comprehensive medical treatme...
Autores principales: | Wu, Cichun, Peng, Wenting, Cheng, Da, Gu, Huimin, Liu, Fei, Peng, Shifang, Fu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817044/ https://www.ncbi.nlm.nih.gov/pubmed/36643036 http://dx.doi.org/10.14218/JCTH.2022.00106 |
Ejemplares similares
-
Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study
por: Peng, Wenting, et al.
Publicado: (2023) -
Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
por: Wu, Cichun, et al.
Publicado: (2021) -
TRAF2 as a key candidate gene in clinical hepatitis B-associated liver fibrosis
por: Wu, Cichun, et al.
Publicado: (2023) -
Integrated Analysis of Long Noncoding RNA Expression Profiles in Acute-on-Chronic Liver Failure
por: Fu, Xiaoyu, et al.
Publicado: (2021) -
Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure
por: Hessel, Franz P
Publicado: (2006)